Report - RECIDIVERENDE RESPIRATOIRE INFECTIES · Severe CAP (PSI risk category V) No randomized double-blind placebo-controlled trials moxifloxacin 400 mg 1 dd iv/po. or penicillin 1 ME 6

Please pass captcha verification before submit form